Company Overview and News

 
BRIEF-Technicolor Appoints Laurent Carozzi As CFO

2018-03-05 reuters
* TECHNICOLOR SA - LAURENT CAROZZI IS JOINING TECHNICOLOR FROM PUBLICIS WHERE HE WAS DEPUTY OF GROUP CFO
Upvote Downvote

 
Technicolor SA 2017 Q4 - Results - Earnings Call Slides

2018-02-21 seekingalpha
The following slide deck was published by Technicolor SA in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

 
TiVo Wins Patent Case Against Comcast at U.S. Trade Agency - Bloomberg

2017-11-22 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Would a Weinstein Co. Name Change Wipe the Stain of Harvey’s Scandal? - Bloomberg

2017-10-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
TiVo Stock Soars On Initial Comcast Lawsuit Ruling

2017-05-30 zacks
Shares of TiVo (TIVO - Free Report) popped 10% in morning trading Tuesday on news that it earned an early favorable ruling in a patent lawsuit against Comcast (CMCSA - Free Report) . Now, the struggling digital television recording company, which once helped change the industry forever, might be positioned for further positive gains.
Upvote Downvote

 
Their Finest review: Bill Nighy scores the best bits of this Blitz pic

2017-04-19 smh.com.au
Nostalgia for the Blitz has become one of Britain's most marketable commodities, especially now collective memory of the reality is starting to vanish.
Upvote Downvote

 
Global $3.8 Billion 4K Set-top Box (STB) Market Analysis & Trends 2016-2025 - Product (Hybrid, Satellite, IP & Cable STBs) & Technology (OTT, IPTV & DTT) - Research and Markets

2017-02-20 prnewswire
Research and Markets has announced the addition of the "Global 4K Set-top Box (STB) Market Analysis & Trends - Product (Hybrid, Satellite, IP & Cable STBs), Technology (OTT (Over the Top), Internet Protocol Television (IPTV) & DTT (Direct Terrestrial Transmission)) - Forecast to 2025" report to their offering.
Upvote Downvote

 
AllSeen Alliance Merges With Open Connectivity Foundation to Accelerate the Internet of Things

2016-10-11 indiainfoline
The Open Connectivity Foundation (OCF), sponsor of the IoTivity open source project, and AllSeen Alliance, which provides the AllJoyn® open source IoT framework, announced that the two organizations’ boards have approved a merger under the OCF name and bylaws. This merger will advance interoperability between connected devices from both groups, enabling the full operating potential of IoT and representing a significant step towards a connected ecosystem.
Upvote Downvote

 
RealNetworks Appoints Bill Patrizio President Of Consumer Media

2016-09-19 prnewswire
SEATTLE, Sept. 19, 2016 /PRNewswire/ -- RealNetworks, Inc. (NASDAQ: RNWK) today announced that media industry veteran Bill Patrizio has joined the company as President of Consumer Media.
Upvote Downvote

 
Technicolor Seems To Be Painting A Bright Picture

2016-09-18 seekingalpha
As we approach the new year, we scanned for companies in France that have earnings as fine as their wine.
Upvote Downvote

 
Final Results

2016-07-11 londonstockexchange
Pinewood Group plc, a world leading studio and production services operator, delivers another year of strong growth. 
Upvote Downvote

 
European stocks down for a second straight day

2016-06-01 marketwatch
European stocks finished lower Wednesday, with mining shares among the biggest laggards after lackluster Chinese manufacturing data underscored worries about the health of the world’s second-largest economy.
Upvote Downvote

 
Audio Codec Market by Component, Channel Type, Compression Type, Application, & Geography - Global Forecast to 2022

2016-05-30 prnewswire
LONDON, May 30, 2016 /PRNewswire/ -- "The audio codec market growth is directly linked with the growth of the mobile phone and tablet industry" The audio codec market was valued at USD 5.49 billion in 2015 and is expected to reach USD 7.44 billion by 2022, at a CAGR of 4.3% between 2016 and 2022. This growth can be attributed to the huge demand for mobile phones and tablets. The rising middle class population and improved disposable income and availability of mobile phones and tablets at low cost are the driving factors for the growth of mobile phones and tablets.
Upvote Downvote

 
Audio Codec Market Worth 7.44 Billion USD by 2022

2016-05-17 prnewswire
According to the new market research report on the "Audio Codec Market by Component (Hardware and Software), Channel Type (Mono-Codec, Stereo Codec, and Multi-channel Codec), Compression Type (Non-Compression, Lossless Compression, and Lossy Compression), Application, & Geography - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to reach USD 7.44 Billion by 2022, at a CAGR of 4.
Upvote Downvote

 
Set-Top Boxes Market (By Type - Cable Set-Top Boxes, Satellite Set-Top Boxes, IPTV Set-Top Boxes and HBB Set-Top Boxes; By Video Quality - Standard Definition Set-Top Boxes and High Definition Set-Top Boxes) Market - Global Industry Analysis, Size,

2016-03-30 prnewswire
NEW YORK, March 30, 2016 /PRNewswire/ -- A set-top box (STB) is a device that is used to convert the video content transmitted from a pay TV operator to a format compatible with an end-user or subscriber TV. STBs may receive the video content from satellite, terrestrial, cable or Internet-based transmission. STBs offer a greater number of channels compared to conventional broadcasting services and further improve the quality of the video content considerably.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...